For research use only
| Cat No. | ABC-TC0882 |
| Product Type | Human Ovarian Cancer Cell Lines |
| Species | Human |
| Growth Conditions | 37 ℃, 5% CO2 |
| Source Organ | Ovary |
OVKATE: A tumorigenic, EGFR-positive ovarian cancer cell line. Derived from serous adenocarcinoma, it's ideal for targeted therapy & biomarker research.
| Species | Human |
| Cat.No | ABC-TC0882 |
| Product Category | Tumor Cell Lines |
| Size/Quantity | 1 vial |
| Shipping Info | Dry Ice |
| Growth Conditions | 37 ℃, 5% CO2 |
| Source Organ | Ovary |
| Biosafety Level | 1 |
| Storage | Liquid Nitrogen |
| Product Type | Human Ovarian Cancer Cell Lines |
The OVKATE cell line is a key model for human ovarian carcinoma research. It is used in genomics studies and for establishing xenograft models, allowing in-depth exploration of the molecular mechanisms underlying ovarian cancer. In addition, OVKATE cells support investigations into the regulation of intermediate filament expression and are employed in testing the anti-proliferative effects of candidate drugs, facilitating the development of innovative therapies for ovarian cancer.
When you publish your research, please cite our product as “AcceGen Biotech Cat.# XXX-0000”. In return, we’ll give you a $100 coupon. Simply click here and submit your paper’s PubMed ID (PMID).
OVKATE cells were originally isolated from ovary of a stage IIIc ovarian tumor patient.
The OVKATE cell line grow slowly. The doubling time would be over 1 week.
Yes. Cells are form tumors by SC injection.
